Uncategorized

Seaport and Hemab file for IPOs, with Kailera expected to price soon

Published

5 hours ago

on

The spring IPO cohort is starting to take shape.

On Friday night, neuroscience drug developer Seaport Therapeutics and blood clotting disorder biotech Hemab Therapeutics both filed for …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version